A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
Discipline-specific Malaria Eradication Research Agenda (malERA) Consultative Groups have recognized several cross-cutting issues that must be addressed to prevent repetition of some of the mistakes of past malaria elimination campaigns in future programs. Integrated research is required to develop a decision-making framework for the switch from malaria control to elimination. Similarly, a strong economic case is needed for the very long-term financial support that is essential for elimination. Another cross-cutting priority is the development of improved measures of intensity of transmission, especially at low and nonrandom levels. Because sustained malaria elimination is dependent on a functioning health system, a further key cross-cutting research question is to determine how inputs for malaria can strengthen health systems, information systems, and overall health outcomes. Implementation of elimination programs must also be accompanied by capacity building and training to allow the assessment of the impact of new combinations of interventions, new roles for different individuals, and the operational research that is needed to facilitate program expansion. Finally, because community engagement, knowledge management, communication, political, and multisectoral support are critical but poorly understood success factors for malaria elimination, integrated research into these issues is vital.
Vyšlo v časopise:
A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000404
Kategorie:
Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000404
Souhrn
Discipline-specific Malaria Eradication Research Agenda (malERA) Consultative Groups have recognized several cross-cutting issues that must be addressed to prevent repetition of some of the mistakes of past malaria elimination campaigns in future programs. Integrated research is required to develop a decision-making framework for the switch from malaria control to elimination. Similarly, a strong economic case is needed for the very long-term financial support that is essential for elimination. Another cross-cutting priority is the development of improved measures of intensity of transmission, especially at low and nonrandom levels. Because sustained malaria elimination is dependent on a functioning health system, a further key cross-cutting research question is to determine how inputs for malaria can strengthen health systems, information systems, and overall health outcomes. Implementation of elimination programs must also be accompanied by capacity building and training to allow the assessment of the impact of new combinations of interventions, new roles for different individuals, and the operational research that is needed to facilitate program expansion. Finally, because community engagement, knowledge management, communication, political, and multisectoral support are critical but poorly understood success factors for malaria elimination, integrated research into these issues is vital.
Zdroje
1. BremanJG
de QuadrosCA
DowdleWR
FoegeWH
HendersonDA
2011 The role of research in viral disease eradication and elimination programs: Lessons for malaria eradication. PLoS Med 8 e1000405 10.1371/journal.pmed.1000405
2. NájeraJ
González-SilvaM
Alonso, PL 2011 Some lessons for the future from the Global Malaria Eradication Programme (1955–1969). PLoS Med 8 e1000412 doi:10.1371/journal.pmed.1000412
3. Roll Back Malaria 2008 Global malaria action plan. Geneva: Roll Back Malaria Partnership. Available: http://rbm.who.int/gmap/gmap.pdf
4. The malERA Consultative Group on Health Systems and Operational Research 2011 A research agenda for malaria eradication: Health systems and operational research. PLoS Med 8 e1000397 doi:10.1371/journal.pmed.1000397
5. RobertsDR
ManguinS
MouchetJ
2000 DDT house spraying and re-emerging malaria. Lancet 356 330 332
6. Feachem RGA and the Malaria Elimination Group 2009 Shrinking the malaria map: a guide on malaria elimination for policy makers. San Francisco The Global Health Group, Global Health Sciences, University of California, San Francisco
7. MillsA
LubellY
HansonK
2008 Malaria eradication: The economic, financial and institutional challenge. Malar J 7 S1 S11
8. USAID 2010 Celebrate, innovate and sustain: toward 2015 and beyond. The United States' strategy for meeting the. Millennium Development. Available: http://www.usaid.gov/our_work/mdg/US_MDG_Strategy.pdf
9. OECD 2005 Paris Declaration on Aid Effectiveness: Ownership, harmonization, alignment, results and mutual accountability. Paris OECD
10. Accra High Level Forum 2008 Accra agenda for action. 3rd high level forum on aid effectiveness. Available: http://siteresources.worldbank.org/ACCRAEXT/Resources/4700790-1217425866038/AAA-4-SEPTEMBER-FINAL-16h00.pdf
11. The malERA Consultative Group on Monitoring, Evaluation, and Surveillance 2011 A research agenda for malaria eradication: Monitoring, evaluation, and surveillance. PLoS Med 8 e1000400 doi:10.1371/journal.pmed.1000400
12. The malERA Consultative Group on Diagnoses and Diagnostics 2011 A research agenda for malaria eradication: Diagnoses and diagnostics. PLoS Med 8 e1000396 doi:10.1371/journal.pmed.1000396
13. HaySI
SmithDL
SnowRW
2008 Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis; 8 369 378
14. The malERA Consultative Group on Modeling 2011 A research agenda for malaria eradication: Modeling. PLoS Med 8 e1000403 doi:10.1371/journal.pmed.1000403
15. World Health Organization 2009 Deployment of artemetherlumefantrine with rapid diagnostic tests at community level, Raya Valley, Tigray, Ethiopia. Geneva: World Health Organization. Available: http://www.who.int/malaria/publications/techreport_rdt_tigray.pdf
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
- The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
- Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies